Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 84, Issue 1, Pages 75-82Publisher
NATURE PUBLISHING GROUP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study
Liyu Chen, Hua Dai, Jiayi Wang, Ming Wang, Yuanji Ma, Fanghua Ma, Changmin Li, Lang Bai, Lingyao Du, Hong Tang
ANNALS OF TRANSLATIONAL MEDICINE (2022)
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins
Nancy H. C. Loos, Jos H. Beijnen, Alfred H. Schinkel
BIOMEDICINE & PHARMACOTHERAPY (2023)
Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study
Liyu Chen, Hua Dai, Jiayi Wang, Ming Wang, Yuanji Ma, Fanghua Ma, Changmin Li, Lang Bai, Lingyao Du, Hong Tang
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study
Jose L. Blanco, Jhon Rojas, Elisa de Lazzari, Alexy Inciarte, Mar Subirana, Pilar Callau, Maria Martinez-Rebollar, Montserrat Laguno, Josep Mallolas, Lorena de la Mora, Berta Torres, Ana Gonzalez-Cordon, Esteban Martinez
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
Caroline S. Foo, Rana Abdelnabi, Suzanne J. F. Kaptein, Xin Zhang, Sebastiaan ter Horst, Raf Mols, Leen Delang, Joana Rocha-Pereira, Lotte Coelmont, Pieter Leyssen, Kai Dallmeier, Valentijn Vergote, Elisabeth Heylen, Laura Vangeel, Arnab K. Chatterjee, Pieter P. Annaert, Patrick F. Augustijns, Steven De Jonghe, Dirk Jochmans, Mieke Gouwy, Seppe Cambier, Jennifer Vandooren, Paul Proost, Christine van Laer, Birgit Weynand, Johan Neyts
ANTIVIRAL RESEARCH (2022)
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy
Maor Wanounou, Yoseph Caraco, Rene H. Levy, Meir Bialer, Emilio Perucca
CLINICAL PHARMACOKINETICS (2022)
Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir
Ruben Gonzalez-Garcia, Joan-Ramon Roma, Maria Rodriguez-Garcia, Natalia Arranz, Juan Ambrosioni, Marta Bodro, Maria-Angeles Castel, Federic Cofan, Gonzalo Crespo, Fritz Diekmann, Marta Farrero, Alejandro Forner, Ana LLigona, Maria Angeles Marcos, Asuncion Moreno, Pablo Ruiz, Dolors Soy, Merce Brunet, Jose M. Miro, Montse Tuset
CLINICAL MICROBIOLOGY AND INFECTION (2023)
Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat
Ruxandra-Cristina Marin, Adrian Streinu-Cercel, Lavinia Cristina Moleriu, Simona Gabriela Bungau
BIOMEDICINE & PHARMACOTHERAPY (2022)
Management of Antiretroviral Therapy with Boosted Protease Inhibitors - Darunavir/Ritonavir or Darunavir/Cobicistat
Ruxandra-Cristina Marin, Tapan Behl, Nicoleta Negrut, Simona Bungau
BIOMEDICINES (2021)
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19
Benjamin Batteux, Sandra Bodeau, Valerie Gras-Champel, Sophie Liabeuf, Jean-Philippe Lanoix, Jean-Luc Schmit, Claire Andrejak, Yoann Zerbib, Guillaume Haye, Kamel Masmoudi, Anne-Sophie Lemaire-Hurtel, Youssef Bennis
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China
Peng-Le Guo, Hao-Lan He, Xie-Jie Chen, Jin-Feng Chen, Xiao-Ting Chen, Yun Lan, Jian Wang, Pei-Shan Du, Huo-Lin Zhong, Hong Li, Cong Liu, Li-Ya Li, Feng-Yu Hu, Xiao-Ping Tang, Wei-Ping Cai, Ling-Hua Li
FRONTIERS IN PHARMACOLOGY (2021)
Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani, Afshin Moniri, Zahra Abtahian, Somayeh Ghadimi, Melika Valizadeh, Jalal Heshmatnia, Maryam Sadat Mirenayat, Atefeh Abedini, Arda Kiani, Alireza Eslaminejad, Seyed MohammadReza Hashemian, Hamidreza Jamaati, Alireza Zali, Ali Akbar Velayati, Payam Tabarsi
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
Periklis Panagopoulos, Vasilis Petrakis, Maria Panopoulou, Grigorios Trypsianis, Theano Penlioglou, Ioannis Pnevmatikos, Dimitrios Papazoglou
JOURNAL OF CHEMOTHERAPY (2021)
Effects of a ritonavir-containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects
Jiuhong Zha, Qi Jiang, Betty B. B. Yao, Daniel E. E. Cohen, David C. C. Carter, Rajeev M. M. Menon
PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia
Zachary F. Caffall, Bradley J. Wilkes, Ricardo Hernandez-Martinez, Joseph E. Rittiner, Jennifer T. Fox, Kanny K. Wan, Miranda K. Shipman, Steven A. Titus, Ya-Qin Zhang, Samarjit Patnaik, Matthew D. Hall, Matthew B. Boxer, Min Shen, Zhuyin Li, David E. Vaillancourt, Nicole Calakos
SCIENCE TRANSLATIONAL MEDICINE (2021)
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals
Nareshkumar Poopalasingam, Michael Korenkov, Artem Ashurov, Janina Strobel, Irina Fish, Martin Hellmich, Henning Gruell, Clara Lehmann, Eva Heger, Florian Klein
JOURNAL OF CLINICAL VIROLOGY (2022)
Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry
Bianza T. Mbavha, Comfort R. Kanji, Nadina Stadler, Julia Stingl, Andrea Stanglmair, Catharina Scholl, William Wekwete, Collen Masimirembwa
PHARMACOGENETICS AND GENOMICS (2022)
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes
Jochen Fracowiak, Tatjana Huebner, Steffen Hess, Christoph Roethlein, Daria Langner, Udo Schneider, Felix Falkenberg, Catharina Scholl, Roland Linder, Julia Stingl, Britta Haenisch, Michael Steffens
PHARMACOGENOMICS JOURNAL (2022)
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis
Seenae Eum, Franklin Sayre, Adam M. Lee, Julia C. Stingl, Jeffrey R. Bishop
PHARMACOTHERAPY (2022)
Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera
Marie-Luise Herrlein, Sascha Hein, Tobias Zahn, Ines Mhedhbi, Jan Raupach, Younes Husria, Nuka Ivalu Benz, Jonathan Eisert, Daniela Bender, Vanessa Haberger, Florian D. Hastert, Lisa Henss, Barbara S. Schnierle, Julia C. Stingl, Michael Dreher, Eberhard Hildt
VIRUSES-BASEL (2022)
Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection
Cynthia Huber, Tim Friede, Julia Stingl, Norbert Benda
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2022)
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
Henning Gruell, Jesper D. Gunst, Yehuda Z. Cohen, Marie H. Pahus, Jakob J. Malin, Martin Platten, Katrina G. Millard, Martin Tolstrup, R. Brad Jones, Winnifer D. Conce Alberto, Julio C. C. Lorenzi, Thiago Y. Oliveira, Tim Kuemmerle, Isabelle Suarez, Cecilia Unson-O'Brien, Lilian Nogueira, Rikke Olesen, Lars Ostergaard, Henrik Nielsen, Clara Lehmann, Michel C. Nussenzweig, Gerd Faetkenheuer, Florian Klein, Marina Caskey, Ole S. Sogaard
LANCET MICROBE (2022)
Viral Load Dynamics in SARS-CoV-2 Omicron Breakthrough Infections
Felix Dewald, Susanne Detmer, Martin Pirkl, Martin Hellmich, Eva Heger, Maximilian Herrmann, Clara Lehmann, Janine Zweigner, Florian Klein
JOURNAL OF INFECTIOUS DISEASES (2022)
A population pharmacokinetic model of remdesivir and its major metabolites based on published mean values from healthy subjects
Ahmed Abouellil, Muhammad Bilal, Max Taubert, Uwe Fuhr
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)
Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations
Ingmar Bergs, Katja S. Just, Catharina Scholl, Michael Dreher, Julia C. Stingl
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Population Pharmacokinetics as a Tool to Reevaluate the Complex Disposition of Ethanol in the Fed and Fasted States
Soeren Buesker, Alan Wayne Jones, Robert G. Hahn, Max Taubert, Ulrich Klotz, Matthias Schwab, Uwe Fuhr
JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports
Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Stingl, Patrick Christ, Ursula Koberle, Matthias Schmid, Antje Neubert, Bernhardt Sachs
PEDIATRIC DRUGS (2023)
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions
Laura Maria Fuhr, Fatima Zahra Marok, Uwe Fuhr, Dominik Selzer, Thorsten Lehr
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units
Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad-Santos, Antonio Portoles, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)
In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans
Chih-hsuan Hsin, Annett Kuehne, Yi Gu, Gabriele Jedlitschky, Yohannes Hagos, Dirk Gruendemann, Uwe Fuhr
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)